Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Iicis 2023 PDF full book. Access full book title Iicis 2023.
| Author | : João Manuel R. S. Tavares |
| Publisher | : Springer Nature |
| Total Pages | : 588 |
| Release | : |
| Genre | : |
| ISBN | : 9819989760 |
| Author | : Munir Mandviwalla |
| Publisher | : Springer Nature |
| Total Pages | : 464 |
| Release | : |
| Genre | : |
| ISBN | : 3031611756 |
| Author | : Ahmed, Zeinab E. |
| Publisher | : IGI Global |
| Total Pages | : 426 |
| Release | : 2024-04-22 |
| Genre | : Education |
| ISBN | : |
The digital age has ushered in an era where students must be equipped not only with traditional knowledge but also with the skills to navigate an increasingly interconnected and technologically driven world. As traditional teaching methods encounter the complexities of the 21st century, the demand for innovation becomes more apparent. This paves the way for the era of artificial intelligence (AI), a technological frontier that carries the potential to reshape education fundamentally. AI-Enhanced Teaching Methods recognizes the urgency of the ongoing technological shift and delves into an exploration of how AI can be effectively harnessed to redefine the learning experience. The book serves as a guide for educators, offering insights into navigating between conventional teaching methodologies and the possibilities presented by AI. It provides an understanding of AI's role in education, covering topics from machine learning to natural language processing. Ethical considerations, including privacy and bias, are thoroughly addressed with thoughtful solutions as well. Additionally, the book provides valuable support for administrators, aiding in the integration of these technologies into existing curricula.
| Author | : Abhishek Kathuria |
| Publisher | : Springer Nature |
| Total Pages | : 141 |
| Release | : |
| Genre | : |
| ISBN | : 3031600037 |
| Author | : Yiliu Paul Tu |
| Publisher | : Springer Nature |
| Total Pages | : 480 |
| Release | : |
| Genre | : |
| ISBN | : 3031603249 |
| Author | : Elsabé Loots |
| Publisher | : AOSIS |
| Total Pages | : 318 |
| Release | : 2023-04-29 |
| Genre | : Business & Economics |
| ISBN | : 1779953100 |
This book aims to advance the knowledge on the future of business education in South Africa and to allow all relevant role players (universities and industry) the opportunity to debate and share ideas on how to best position business education to optimally serve the interest of students and the dynamic changes taking place in the world of work. Although some of these changes have taken shape before 2020, the COVID-19 pandemic has accelerated the need and pace for change. If business schools (in our context, faculties of economic and management sciences) do not adapt rapidly, they will be left behind by other up-and-coming industry providers. The research scope covers all business-related undergraduate and postgraduate economics, management and accounting programmes, excluding MBA programmes.
| Author | : |
| Publisher | : Elsevier |
| Total Pages | : 276 |
| Release | : 2024-04-23 |
| Genre | : Science |
| ISBN | : 0443235473 |
Targeting Signaling Pathways in Solid Tumors, Part A, Volume 385 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Drugging the Undruggable: Advances in Targeting KRAS Signaling in Solid Tumors, Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression, Importance of targeting various cell signaling pathways in solid cancers, Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics, Factors affecting heterogeneity in breast cancer microenvironment: A narrative review, and much more. Additional sections cover Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled Provides the latest information on cancer research Offers outstanding and original reviews on a range of cancer research topics Serves as an indispensable reference for researchers and students alike
| Author | : Ayaz Shahid |
| Publisher | : Frontiers Media SA |
| Total Pages | : 353 |
| Release | : 2024-04-15 |
| Genre | : Science |
| ISBN | : 2832547842 |
Cancer is the second leading cause of death. Every year, many anticancer drug candidates are discovered and synthesized, but the major challenge lies in identifying, characterizing and evaluating their efficacy. The aim of this Research Topic, "New Mechanisms for Anti-Cancer Drugs" is to collect a group of publications focused on novel chemical compounds exhibiting new modes of actions and/or new target proteins to fulfill their cytotoxic activity on cancer cells. In this context, we will also be pleased to consider studies on drug repurposing, including approved, discontinued, and shelved drugs, when anti-cancer activity results from an unexpected mode of action.
| Author | : IEEE Staff |
| Publisher | : |
| Total Pages | : 0 |
| Release | : 2023-06-23 |
| Genre | : |
| ISBN | : |
The 23rd IEEE ACIS International Conference on Computer and Information Science brings together scientists, engineers, computer users, and students to exchange and share their experiences, new ideas, and research results about all aspects (theory, applications and tools) of computer and information science, and discuss the practical challenges encountered and the solutions adopted
| Author | : Patrick Schmidt |
| Publisher | : Frontiers Media SA |
| Total Pages | : 160 |
| Release | : 2024-02-16 |
| Genre | : Medical |
| ISBN | : 2832544916 |
Cancer Immunotherapy apart from checkpoint inhibitors is a highly personalized medicine that puts the patient's cells in the focus of drug manufacturing and promises outcomes that rarely have been seen in the history of cancer treatment. CAR-T cells can be mentioned here as the key example that has gained FDA and EMA approvals as the first living drugs for the treatment of leukemias and is now under clinical investigation for application in solid tumors as well. Improvements in cellular engineering in combination with advanced sequencing methods have made it possible to discover tumor-mutation-specific T-cell receptors that can be used to redirect effector cells toward the malignant cell pool with high specificity. This approach opens the opportunity to drug driver mutations that are occurring in a group of patients as well as to design unique patient individual treatment regimens.
